IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ADAMO, Marianna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.119
EU - Europa 1.654
AS - Asia 1.145
SA - Sud America 12
OC - Oceania 9
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 5.951
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.102
HK - Hong Kong 431
IT - Italia 419
CN - Cina 341
DE - Germania 318
SG - Singapore 268
FI - Finlandia 228
IE - Irlanda 165
GB - Regno Unito 156
UA - Ucraina 138
CZ - Repubblica Ceca 55
IN - India 37
RU - Federazione Russa 37
SE - Svezia 35
FR - Francia 28
BE - Belgio 23
JP - Giappone 16
TR - Turchia 15
CA - Canada 14
ES - Italia 11
NL - Olanda 9
AU - Australia 7
KR - Corea 7
ID - Indonesia 6
IR - Iran 6
PL - Polonia 6
AT - Austria 4
BR - Brasile 4
EU - Europa 4
TW - Taiwan 4
AR - Argentina 3
EG - Egitto 3
GR - Grecia 3
PH - Filippine 3
SA - Arabia Saudita 3
VN - Vietnam 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CH - Svizzera 2
HR - Croazia 2
LU - Lussemburgo 2
LV - Lettonia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PE - Perù 2
SI - Slovenia 2
TN - Tunisia 2
VE - Venezuela 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MU - Mauritius 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
Totale 5.951
Salva come PNG Salva come JPEG
Città #
Chandler 449
Hong Kong 427
Fairfield 364
Ashburn 266
Princeton 238
Helsinki 191
Beijing 175
Houston 169
Dublin 165
Woodbridge 165
Seattle 154
Singapore 146
Wilmington 139
New York 138
Cambridge 130
Jacksonville 116
Romola 89
Ann Arbor 73
Shanghai 68
Milan 54
Brno 44
Brescia 37
Lappeenranta 34
Frankfurt am Main 31
Los Angeles 30
San Diego 29
London 28
Des Moines 27
Pune 24
Brussels 23
Munich 22
Brindisi 19
Nanjing 15
Prevalle 15
Kilburn 14
Washington 14
Rome 13
Olomouc 9
San Francisco 9
Strasbourg 9
Tokyo 9
Changsha 8
Chicago 8
Chiswick 8
West Jordan 8
Acton 7
Boardman 7
Jiaxing 7
Shenyang 7
Bari 6
Nanchang 6
North York 6
Prescot 6
Stockholm 6
Trieste 6
Venice 6
Dearborn 5
Falkenstein 5
Haikou 5
Hebei 5
Jinan 5
Kocaeli 5
New Bedfont 5
Zhengzhou 5
Amsterdam 4
Augusta 4
Curno 4
Gangnam-gu 4
Jakarta 4
Melbourne 4
Nürnberg 4
Padova 4
Taipei 4
Toronto 4
Vienna 4
Warsaw 4
A Coruña 3
Azzano San Paolo 3
Berlin 3
Bologna 3
Canberra 3
Edinburgh 3
Hanover 3
Hounslow 3
Kulgam 3
Kunming 3
Lancaster 3
Lviv 3
Madrid 3
Marburg 3
Miami 3
Moscow 3
Nantes 3
Norwalk 3
Potsdam 3
Quezon City 3
Ravenna 3
Riyadh 3
Soncino 3
Springfield 3
Totale 4.433
Salva come PNG Salva come JPEG
Nome #
May 2020 at a glance: ischaemic heart failure and sex-related differences 210
Effectiveness of MitraClip therapy in patients with refractory heart failure 147
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 142
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: Early and midterm outcomes 140
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 140
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 133
EkoSonic Endovascular System for patients with acute pulmonary embolism and contraindication to systemic fibrinolysis 101
August 2020 at a glance: focus on neurohormonal antagonists and electrolytes 100
January 2020 at a glance: translational medicine, predictors of outcome and treatments 78
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 77
September 2019 at a glance: focus on devices 76
Role of different vascular approaches on transcatheter aortic valve implantation outcome: a single-center study. 69
Trans-axillary versus trans - aortic approach for transcatheter aortic valve implantation with corevalve revalving system: insights from multicenter experience 67
Highlights in heart failure 64
December 2019 at a glance: economic burden, co-morbidities, and prognosis 61
Life-saving transcatheter aortic valve implantation for acute severe aortic regurgitation due to rheumatoid arthritis and complicated by cardiogenic shock 60
Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project 59
Highlights in valvular heart diseases 59
Role of nutrition in heart failure patients 57
April 2020 at a glance: epidemiology, prevention, and biomarkers 55
COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease 54
October 2019 at a glance: epidemiology, prevention, and modes of death 54
Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair 53
Prognostic Impact of Heart Failure History in Patients with Secondary Mitral Regurgitation Treated by MitraClip 53
Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials? 52
Percutaneous treatment of mitral regurgitation: looking for a final model 52
November 2019 at a glance. Chronic and acute heart failure: from epidemiology to treatment 51
ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19 51
Transcatheter therapies for tricuspid valve regurgitation 49
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 49
COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation 49
Percutaneous valve repair of functional mitral regurgitation: aiming at optimal and durable results 48
Prognostic Value of Pre-operative Atrial Fibrillation in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation 47
Atrial fibrillation in the COVID-19 era: Simple bystander or marker of increased risk? 45
Il dronedarone: in quali pazienti e con quali associazioni? 42
February 2020 at a glance: acute heart failure and cardio-oncology 42
Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology 41
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 39
Renal failure after trans-catheter aortic valve implantation 39
September 2020 at a glance: focus on heart failure with preserved ejection fraction and medical therapy 38
July 2020 at a glance: focus on imaging and cardiomyopathies 37
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 36
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC 36
A Score to Assess Mortality After Percutaneous Mitral Valve Repair 35
Prognostic value of right ventricle to pulmonary artery coupling in transcatheter aortic valve implantation recipients 35
A meta-analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patients 35
Right ventricular deformation and right ventricular-arterial coupling in patients with heart failure due to severe aortic stenosis undergoing TAVI: long-term results. 34
Patient with heart failure: importance to treat valvular diseases 34
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: The APACHE pilot study 33
Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: Insights from the multicenter GRASP-IT registry 32
March 2020 at a glance: heart failure with preserved ejection fraction, left atrial myopathy, atrial fibrillation and cardiac amyloidosis 32
Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX) OCT study 31
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 30
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors 30
Reply: Explaining differing outcomes from the COAPT and MITRA-FR trials using disproportionate and proportionate secondary mitral regurgitation 30
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 29
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 29
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 29
Heart failure in the last year: progress and perspective 29
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 29
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 28
Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score 28
Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: Results of an EAPCI survey 28
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials 28
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 27
[Advances in heart failure treatment: a summary of 50 years of evolution] 27
Percutaneous Edge-to-Edge Mitral Valve Repair: Beyond the Left Heart 27
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy 26
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 26
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage] 25
Bioequivalence and excipients: the case of tirofiban. A warning from the Italian Society of Interventional Cardiology (SICI-GISE) | [Bioequivalenza ed eccipienti: il caso del tirofiban. Un “warning” della Società Italiana di Cardiologia Interventistica (SICI-GISE)] 25
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 24
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction 24
Updates in heart failure: sodium glucose co-transporter 2 inhibitors and beyond - major changes are coming 24
March 2023 at a glance: pathophysiology, medical therapy and devices 23
Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation: A Patient-Level, Multicenter Analysis 23
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 23
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial 23
Direct transcatheter aortic valve implantation with self-expandable bioprosthesis: Feasibility and safety 23
Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration 23
Does smoking habit affect the randomized comparison of 6 versus 24-month dual antiplatelet therapy duration? Insights from the PRODIGY trial 23
Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry) 22
April 2022 at a glance: focus on prevention, acute heart failure and heart failure with preserved ejection fraction 22
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 22
Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion 22
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 22
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 22
[Transcatheter devices for chronic heart failure: state of the art] 22
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation 22
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 22
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 22
Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration 21
Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation 21
Long-term outcomes after transcatheter aortic valve replacement in nonagenarians: a multicenter age-based analysis 21
August 2021 at a glance: focus on cardiomyopathies, medical treatment and devices 21
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction 21
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 21
OCT Appraisal of Residual Thrombus Burden in Patients With STEMI Undergoing Intraprocedural Versus Post-Stenting Prolonged Bivalirudin Infusion: The MATRIX OCT Study 21
Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients: Incidence and Predictors of 2-Year Good Outcome 21
Left atrial volume index and outcome after transcatheter edge-to-edge valve repair for secondary mitral regurgitation 20
Totale 4.424
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.187
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020396 0 0 18 33 26 48 42 50 31 76 38 34
2020/20211.091 77 145 44 141 41 75 162 102 71 118 71 44
2021/2022728 23 102 22 83 21 57 15 76 34 51 42 202
2022/20231.347 150 48 20 115 101 377 10 144 201 19 85 77
2023/20242.078 111 39 174 150 117 243 144 62 502 79 81 376
2024/2025267 46 47 174 0 0 0 0 0 0 0 0 0
Totale 6.188